MoneyNew rules to dampen Chinese interest to list in Europe, say bankersMay 22, 202369SHANGHAI/SINGAPORE, May 22 (Reuters) - Chinese companies' plans to raise capital via listings in London or Zurich are in jeopardy...
InvestingMacron courts Tesla’s Musk and others to ‘Choose France’May 15, 202364France's President Emmanuel Macron meets with businessmen, including SpaceX, Twitter and Tesla CEO Elon Musk, during the 6th edition of...
BankingMarijuana banking bill heads to Senate Banking CommitteeMay 11, 202358May 11 (Reuters) - Shares of pot companies were trading higher on Thursday as the U.S. Senate Banking Committee prepares...
FinancePfizer, BioNTech propose EU pays half for each cancelled COVID dose, Financial Times reportsApril 30, 202358April 30 (Reuters) - Pfizer Inc (PFE.N) and BioNTech's (22UAy.DE) new proposal to the European Union, amid a glut of...
BankingUK stocks finish higher as banks, AstraZeneca climbMarch 27, 202359AstraZeneca rises on late-stage drug trial successUK GDP eyed later in the weekFTSE 100 up 0.9%, FTSE 250 adds 0.2%March...
PensionFactbox: Which companies are affected by SVB collapse?March 13, 2023441March 13 (Reuters) - Startup-focused lender SVB Financial Group (SIVB.O) last week became the largest bank to fail since the...
CurrenciesGalderma posts 2022 revenue growth ahead of planned IPOMarch 13, 2023672022 revenue growth up 13.9% to $3.8bn net salesCore earnings (EBITDA) up 14.5% to $791mExpects 6%-9% net sales growth 2023FRANKFURT,...
CurrenciesNovo obesity drug to launch in the UK soon, says watchdogMarch 8, 202361LONDON, March 8 (Reuters) - Novo Nordisk's (NOVOb.CO) keenly anticipated weight loss medicine, Wegovy, will soon be made available to...
BankingEU adopts fresh sanctions to raise pressure on MoscowFebruary 25, 202370BRUSSELS, Feb 25 (Reuters) - The European Union vowed to increase pressure on Moscow "until Ukraine is liberated" as it...
MoneyWhy Europe’s drug shortages may get worseFebruary 8, 202381Most European countries reporting shortages of antibioticsLow generic drug prices mean razor-thin margins for firmsCompanies say they cannot boost output...